Search Within

Kimberly J Van Zee

Formats
  1. Journal Article (176)
  2. Meeting Abstract (99)
  3. Book Section (10)
  4. Review (3)
  5. Editorial (2)
  6. Miscellaneous (2)
  7. Correspondence (1)
Groups
  1. Surgery (293)
  2. Survivorship Research (293)
  3. Epidemiology and Biostatistics (84)
  4. Department of Pathology and Laboratory Medicine (66)
  5. Biostatistics Service (61)
  6. Department of Medicine (33)

More Groups

People
  1. Monica Morrow (75)
  2. Hiram Cody (65)
  3. Patrick Borgen (64)
  4. Sujata Patil (49)
  5. Alexandra Heerdt (37)
  6. Edi Brogi (29)

More People

Years
  1. 2024 (4)
  2. 2023 (5)
  3. 2022 (5)
  4. 2021 (11)
  5. 2020 (11)
  6. 2019 (12)

More Years

Publications
  1. Annals of Surgical Oncology (114)
  2. Journal of Clinical Oncology (23)
  3. Breast Cancer Research and Treatment (15)
  4. Cancer (11)
  5. Journal of the American College of Surgeons (9)
  6. Laboratory Investigation (8)

More Publications

Publishers
  1. Springer (137)
  2. American Society of Clinical Oncology (23)
  3. Lippincott Williams & Wilkins (16)
  4. American Association for Cancer Research (15)
  5. Elsevier Inc. (14)
  6. Wiley Blackwell (13)

More Publishers

Results (293)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ
    Journal Article

    Morrow, M.; Van Zee, K. J.; Solin, L. J.; Houssami, N.; Chavez-MacGregor, M.; Harris, J. R.; Horton, J.; Hwang, S.; Johnson, P. L.; Marinovich, M. L.; more...
    Annals of Surgical Oncology (2016)

    Fulltext@MSK | Save
  • Impact of age on risk of recurrence of ductal carcinoma in situ: Outcomes of 2996 women treated with breast-conserving surgery over 30 years
    Journal Article

    Cronin, P. A.; Olcese, C.; Patil, S.; Morrow, M.; Van Zee, K. J.
    Annals of Surgical Oncology (2016)

    Fulltext@MSK | Save
  • How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study
    Journal Article

    Mamtani, A.; Barrio, A. V.; King, T. A.; Van Zee, K. J.; Plitas, G.; Pilewskie, M.; El-Tamer, M.; Gemignani, M. L.; Heerdt, A. S.; Sclafani, L. M.; more...
    Annals of Surgical Oncology (2016)

    Fulltext@MSK | Save
  • Age and receptor status do not indicate the need for axillary dissection in patients with sentinel lymph node metastases
    Journal Article

    Mamtani, A.; Patil, S.; Van Zee, K. J.; Cody, H. S. 3rd; Pilewskie, M.; Barrio, A. V.; Heerdt, A. S.; Morrow, M.
    Annals of Surgical Oncology (2016)

    Fulltext@MSK | Save
  • Do LORIS trial eligibility criteria identify a ductal carcinoma in situ patient population at low risk of upgrade to invasive carcinoma?
    Journal Article

    Pilewskie, M.; Stempel, M.; Rosenfeld, H.; Eaton, A.; Van Zee, K. J.; Morrow, M.
    Annals of Surgical Oncology (2016)

    Fulltext@MSK | Save
  • Margins in DCIS: Does residual disease provide an answer?
    Journal Article

    Morrow, M.; Van Zee, K. J.
    Annals of Surgical Oncology (2016)

    Fulltext@MSK | Save
  • Age and receptor status do not indicate the need for axillary dissection in patients meeting ACOSOG Z0011 criteria
    Meeting Abstract

    Mamtani, A.; van Zee, K. J.; Cody, H. S. 3rd; Pilewskie, M.; Barrio, A.; Heerdt, A. S.; Patil, S.; Morrow, M.
    Annals of Surgical Oncology (2016)

    Fulltext@MSK | Save
  • How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study
    Meeting Abstract

    Mamtani, A.; Barrio, A.; King, T. A.; Plitas, G.; Van Zee, K. J.; Pilewskie, M.; El-Tamer, M. B.; Gemignani, M. L.; Heerdt, A. S.; Sclafani, L. M.; more...
    Annals of Surgical Oncology (2016)

    Fulltext@MSK | Save
  • Do LORIS trial eligibility criteria identify a ductal carcinoma in situ (DCIS) patient population at low-risk of upgrade to invasive carcinoma?
    Meeting Abstract

    Pilewskie, M.; Stempel, M.; Rosenfeld, H.; Eaton, A.; Van Zee, K. J.; Morrow, M.
    Annals of Surgical Oncology (2016)

    Fulltext@MSK | Save
  • Age and recurrence risk in 2,996 women with DCIS treated with breast-conserving surgery (BCS)
    Meeting Abstract

    Cronin, P. A.; Olcese, C.; Patil, S.; Morrow, M.; Van Zee, K. J.
    Annals of Surgical Oncology (2016)

    Fulltext@MSK | Save